Indonesia to resume sharing H5N1 avian flu virus samples
Following a two-day meeting organized by the World Health Organization with Indonesian health officials, as well as experts and representatives of around 20 countries which have experienced H5N1 virus animal or human outbreaks, it was announced at a press conference in the capital Jakarata that Indonesia would resume sharing H5N1 avian influenza samples with the WHO, immediately.
The problem arose when Indonesia's Health Minister, Siti Fadilah Supari, ordered the suspension of virus sample sharing with the WHO in protest at the agency's willingness to allow drugmakers access, which meant that Indonesian researchers received no credit for their work in identifying the strain (Marketletter March 5).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze